Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer (Q27005840)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer	scientific article

Statements

scholarly article

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

prostatic hypertrophy

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

Marinus Blankenstein

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Annemieke C Heijboer

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Tim M van der Sluis

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

André N Vis

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

R Jeroen A van Moorselaar

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Hong N Bui

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Eric J H Meuleman

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

language of work or name

1 reference

publication date

12 October 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

BJU International

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

109

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

176-182

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

2

2 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Simultaneous measurement of serum testosterone and dihydrotestosterone by liquid chromatography-tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Serum testosterone levels measured by isotope dilution-liquid chromatography-tandem mass spectrometry in postmenopausal women versus those in women who underwent bilateral oophorectomy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Determination of prostatic androgens in 10 mg of tissue using liquid chromatography-tandem mass spectrometry with charged derivatization

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Liquid chromatography-mass spectrometric assay of androstenediol in prostatic tissue: influence of androgen deprivation therapy on its level

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Development of highly sensitive quantification method for testosterone and dihydrotestosterone in human serum and prostate tissue by liquid chromatography-electrospray ionization tandem mass spectrometry.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Standardization of testosterone measurements in humans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

State-of-the-art of serum testosterone measurement by isotope dilution-liquid chromatography-tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Immunoassays for testosterone in women: better than a guess?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Toward excellence in testosterone testing: a consensus statement

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Tissue content of dihydrotestosterone in human prostatic hyperplasis is not supranormal

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Endogenous steroid levels in the human prostate from birth to old age: a comparison of normal and diseased tissues

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Subnormal Tissue 3α-Androstanediol and Androsterone in Prostatic Hyperplasia*

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

A comparative study of binding, metabolism and endogenous levels of androgens in normal, hyperplastic and carcinomatous human prostate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Comparison of androgen metabolites in benign prostatic hypertrophy (BPH) and normal prostate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Androgen levels in the plasma and prostatic tissues of patients with benign hypertrophy and carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Effect of Megestrol Acetate (Megace®) on Steroid Metabolism and Steroid-Protein Binding in the Human Prostate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: unique importance of extratesticular androgens in men.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Three-month treatment with a long-acting gonadotropin-releasing hormone agonist of patients with benign prostatic hyperplasia: effects on tissue androgen concentration, 5 alpha-reductase activity and androgen receptor content

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

The adrenal androgen androstenediol is present in prostate cancer tissue after androgen deprivation therapy and activates mutated androgen receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

The androgen axis in recurrent prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

The effects of the dual 5alpha-reductase inhibitor dutasteride on localized prostate cancer--results from a 4-month pre-radical prostatectomy study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Persistent intraprostatic androgen concentrations after medical castration in healthy men.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Effect of dutasteride on intraprostatic androgen levels in men with benign prostatic hyperplasia or prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Impaired dihydrotestosterone catabolism in human prostate cancer: critical role of AKR1C2 as a pre-receptor regulator of androgen receptor signaling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Comparison of dihydrotestosterone levels in prostatic cancer metastases and primary prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27005840&oldid=1856108826"